Adrian Murray Brunt

6PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyModels of care and place of birthPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
Development of a Homogeneous Trastuzumab-Triptolide Conjugate for Targeted Therapy of HER2-Overexpressing Ovarian Cancer.

|Nov 22, 2023
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.

Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley

|Mar 01, 2022
The challenge of equipoise: qualitative interviews exploring the views of health professionals and women with multiple ipsilateral breast cancer on recruitment to a surgical randomised controlled feasibility trial.

Jenny Ingram, Lucy Beasant, John Benson

|Feb 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.

Nigel Bundred, Nuria Porta, Adrian Murray Brunt

|Aug 25, 2020
Breast Cancer Management Guidelines During COVID-19 Pandemic.

Manoj Gowda S, Kirti Katherine Kabeer, Sadaf Jafferbhoy

|May 01, 2019
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.

Elizabeth A Mittendorf, Biao Lu, Michelle Melisko

Pageof 1

Frequent Collaborators

1 joint publications

Igor Bondarenko

1 joint publications

Manoj Gowda S

1 joint publications

Kirti Katherine Kabeer

1 joint publications

Sadaf Jafferbhoy